REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the fourth quarter and financial year 2024. Recent Financial and Operating Highlights Revenue for the fourth quarter of 2024 was €1.3 million, which excludes €0.6 million of deferred […]
Day: 13 March 2025
Ministry of Justice Invites Public Consultation on 2025 Budget Law
Ramallah: In a significant step towards promoting transparency and public participation, the Ministry of Justice has published the draft of the Public Budget Law for 2025 on its official electronic platform, known as the “Legislation Platform.” This i…
Israeli Aggression in Tulkarm Persists Amid Intensifying Military Actions
Tulkarm: Israeli aggression enters its 46th day as escalation continues. The Israeli occupation forces continue their aggression on the city of Tulkarm and its camp for the 46th consecutive day, and on the Nur Shams camp for the 33rd day, amid a milit…
Israeli Colonists Hurl Stones at Palestinian Vehicles Near Naqoura
Nablus: Israeli colonists today hurled stones at Palestinian vehicles near the village of Naqoura, northwest of Nablus. Mohammad Azem, head of the Joint Services Council for Villages Northwest of Nablus, reported that a group of colonists from the ill…